Osteoporosis Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
Osteoporosis Drugs Market Analysis:
The expected CAGR of the osteoporosis drugs market during the forecast period (2022–2027) is 3.4%. Various therapies are being explored globally to discover effective treatments for COVID-19. Studies have indicated that osteoporosis drugs, such as denosumab, zoledronate, and calcium, may aid in the treatment of COVID-19, which could potentially increase the market. According to research, osteoporosis treatment can reduce COVID-19 infection by 30–40%. The market’s growth is also driven by an increase in osteoporosis incidence, particularly among young people, and growing R&D investment by biotechnology and pharmaceutical companies. Positive clinical trial results for drugs like raloxifene, a standard orthopedic drug that may alleviate COVID-19 symptoms, could lead to new treatment options and further market growth.
Get the free sample report of the Osteoporosis Drugs Market
Comments
Post a Comment